| Acuity Vision & Eyewear Center | |
|
1193 Tiogue Ave, Coventry, RI 02816-6170 | |
| (401) 823-8200 | |
| (401) 826-8708 |
| Full Name | Acuity Vision & Eyewear Center |
|---|---|
| Type | Facility |
| Speciality | Optometrist |
| Location | 1193 Tiogue Ave, Coventry, Rhode Island |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1790293850 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | ODTG00599 (Rhode Island) | Primary |
| Provider Name | Mark Blasbalg |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1366554420 PECOS PAC ID: 8224133210 Enrollment ID: I20070518000511 |
News Archive
A research team led by an award-winning genomicist at Western University has developed a new method for identifying mutations and prioritizing variants in breast and ovarian cancer genes, which will not only reduce the number of possible variants for doctors to investigate, but also increase the number of patients that are properly diagnosed.
Austrian researchers have developed a simple tool to show the trends in coronavirus infections over time around the world.
As of December 30, 2010, the share capital in Diamyd Medical AB (publ.) is 14,736,117.50 SEK. The total number of votes is 4,241,311.9 and the total number of shares is 29,472,235, divided among 1,437,876 shares of series A (1 vote) and 28,034,359 shares of series B (1/10 vote).
Today AFFiRiS AG announced an important step forward in the development of its vaccine for Parkinson's disease. The vaccine, known as PD01, has undergone numerous preclinical tests which have confirmed its principle of action ("Proof of Concept").
› Verified 2 days ago
| Provider Name | Liane C Prytula |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1669804753 PECOS PAC ID: 5092940882 Enrollment ID: I20131104000172 |
News Archive
A research team led by an award-winning genomicist at Western University has developed a new method for identifying mutations and prioritizing variants in breast and ovarian cancer genes, which will not only reduce the number of possible variants for doctors to investigate, but also increase the number of patients that are properly diagnosed.
Austrian researchers have developed a simple tool to show the trends in coronavirus infections over time around the world.
As of December 30, 2010, the share capital in Diamyd Medical AB (publ.) is 14,736,117.50 SEK. The total number of votes is 4,241,311.9 and the total number of shares is 29,472,235, divided among 1,437,876 shares of series A (1 vote) and 28,034,359 shares of series B (1/10 vote).
Today AFFiRiS AG announced an important step forward in the development of its vaccine for Parkinson's disease. The vaccine, known as PD01, has undergone numerous preclinical tests which have confirmed its principle of action ("Proof of Concept").
› Verified 2 days ago
| Provider Name | Elizabeth R Wassenaar |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1972025187 PECOS PAC ID: 6608123773 Enrollment ID: I20180719003468 |
News Archive
A research team led by an award-winning genomicist at Western University has developed a new method for identifying mutations and prioritizing variants in breast and ovarian cancer genes, which will not only reduce the number of possible variants for doctors to investigate, but also increase the number of patients that are properly diagnosed.
Austrian researchers have developed a simple tool to show the trends in coronavirus infections over time around the world.
As of December 30, 2010, the share capital in Diamyd Medical AB (publ.) is 14,736,117.50 SEK. The total number of votes is 4,241,311.9 and the total number of shares is 29,472,235, divided among 1,437,876 shares of series A (1 vote) and 28,034,359 shares of series B (1/10 vote).
Today AFFiRiS AG announced an important step forward in the development of its vaccine for Parkinson's disease. The vaccine, known as PD01, has undergone numerous preclinical tests which have confirmed its principle of action ("Proof of Concept").
› Verified 2 days ago
| Provider Name | Zachary W Sousa |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1578182192 PECOS PAC ID: 6800214149 Enrollment ID: I20200917002752 |
News Archive
A research team led by an award-winning genomicist at Western University has developed a new method for identifying mutations and prioritizing variants in breast and ovarian cancer genes, which will not only reduce the number of possible variants for doctors to investigate, but also increase the number of patients that are properly diagnosed.
Austrian researchers have developed a simple tool to show the trends in coronavirus infections over time around the world.
As of December 30, 2010, the share capital in Diamyd Medical AB (publ.) is 14,736,117.50 SEK. The total number of votes is 4,241,311.9 and the total number of shares is 29,472,235, divided among 1,437,876 shares of series A (1 vote) and 28,034,359 shares of series B (1/10 vote).
Today AFFiRiS AG announced an important step forward in the development of its vaccine for Parkinson's disease. The vaccine, known as PD01, has undergone numerous preclinical tests which have confirmed its principle of action ("Proof of Concept").
› Verified 2 days ago
| Provider Name | Sara Nichol Crussana |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1568659845 PECOS PAC ID: 2365623923 Enrollment ID: I20210608000061 |
News Archive
A research team led by an award-winning genomicist at Western University has developed a new method for identifying mutations and prioritizing variants in breast and ovarian cancer genes, which will not only reduce the number of possible variants for doctors to investigate, but also increase the number of patients that are properly diagnosed.
Austrian researchers have developed a simple tool to show the trends in coronavirus infections over time around the world.
As of December 30, 2010, the share capital in Diamyd Medical AB (publ.) is 14,736,117.50 SEK. The total number of votes is 4,241,311.9 and the total number of shares is 29,472,235, divided among 1,437,876 shares of series A (1 vote) and 28,034,359 shares of series B (1/10 vote).
Today AFFiRiS AG announced an important step forward in the development of its vaccine for Parkinson's disease. The vaccine, known as PD01, has undergone numerous preclinical tests which have confirmed its principle of action ("Proof of Concept").
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Acuity Vision & Eyewear Center 41 Oak Hill Dr, Exeter, RI 02822-3718 Ph: () - | Acuity Vision & Eyewear Center 1193 Tiogue Ave, Coventry, RI 02816-6170 Ph: (401) 823-8200 |
News Archive
A research team led by an award-winning genomicist at Western University has developed a new method for identifying mutations and prioritizing variants in breast and ovarian cancer genes, which will not only reduce the number of possible variants for doctors to investigate, but also increase the number of patients that are properly diagnosed.
Austrian researchers have developed a simple tool to show the trends in coronavirus infections over time around the world.
As of December 30, 2010, the share capital in Diamyd Medical AB (publ.) is 14,736,117.50 SEK. The total number of votes is 4,241,311.9 and the total number of shares is 29,472,235, divided among 1,437,876 shares of series A (1 vote) and 28,034,359 shares of series B (1/10 vote).
Today AFFiRiS AG announced an important step forward in the development of its vaccine for Parkinson's disease. The vaccine, known as PD01, has undergone numerous preclinical tests which have confirmed its principle of action ("Proof of Concept").
› Verified 2 days ago
Dr. Richard S Liner, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 860 Tiogue Ave, Coventry, RI 02816 Phone: 401-828-2020 Fax: 401-828-4482 | |
Dr. Mark G Blasbalg, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1193 Tiogue Ave, Coventry, RI 02816 Phone: 401-823-8200 Fax: 401-826-8708 | |
Liane Carley Prytula, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1193 Tiogue Ave, Coventry, RI 02816 Phone: 401-823-8200 | |
Coventry Eye Care Associates & Optical Center Optometrist Medicare: Medicare Enrolled Practice Location: 860 Tiogue Ave, Coventry, RI 02816 Phone: 401-828-2020 Fax: 401-828-4482 | |
Teresa N Head, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1193 Tiogue Ave, Coventry, RI 02816 Phone: 401-823-8200 | |
Dr. Stephanie Ann Schultz, OD Optometrist Medicare: May Accept Medicare Assignments Practice Location: 112 Bramble Bush Rd, Coventry, RI 02816 Phone: 401-397-2597 |